Results 131 to 140 of about 144,109 (257)

Efficacy and safety of obinutuzumab in active lupus nephritis. [PDF]

Clin Kidney J
Ene CD, Bruchfeld A.
europepmc   +1 more source

POS0966 OBINUTUZUMAB SHOWS PROMISE IN LUPUS NEPHRITIS REGARDLESS OF BASELINE SEROLOGICAL BIOMARKERS: AN EXPLORATORY POST HOC ANALYSIS OF THE PHASE II NOBILITY STUDY

Edward M Vital, Bernardo Vargas‐Leitón, Julie Rae, Tao Wang, Jason A. Hackney, Cary M. Looney, William F. Pendergraft, Liz Lightstone, B.H. Rovin, Richard Furie, Harini Raghu   +10 more
openalex   +1 more source

Using perception as a strategy: Camouflage, surprise, and the moment of shock related to perception. [PDF]

Iperception
Carbon CC, Dreyer B, Speck M.
europepmc   +1 more source

Is Monotherapy Enough? Rethinking Strategies for Active Lupus Nephritis Network Meta-Analysis of Active Lupus Nephritis Treatment. [PDF]

Kidney Int Rep
Di Maso V, Emmi G.
europepmc   +1 more source

Extremely Long-Lasting B-cell Depletion and BAFFling Effects Following Obinutuzumab-Based Regimen in Lupus Nephritis. [PDF]

Kidney Int Rep
Roccatello D, Sciascia S, De Simone E, Schindler T, Martins E, Mao HA, Rossi D, Fenoglio R.   +7 more
europepmc   +1 more source

nobilitashungariae: List of Historical Surnames of the Hungarian Nobility / A magyar történelmi nemesség családneveinek listája

, 2010
Steven de Zepetnek Totosy
openalex   +1 more source

Intraocular Concentration of Stem Cell Factor/c-KIT and Galectin-1 in Retinal Diseases. [PDF]

Invest Ophthalmol Vis Sci
Choi YJ, Kim HM, Na TY, Park KH, Park SG, Woo SJ.   +5 more
europepmc   +1 more source

Statistical Analyses of the Nobility Family and Household in the Prewar Showa Period [PDF]

, 1996
清美 森岡, Kiyomi Morioka
openalex  

«Mirando le difficoltà di ristorare le rovine del nostro honore». The Neapolitan Nobility and the City of Naples' Embassies in Madrid

, 2014
Ida Mauro
openalex   +2 more sources

Family cultural capital and academic achievement: the mediating roles of habitus and field. [PDF]

Front Psychol
Jin M, Gootjes DC, Zhao H, Gu Y.
europepmc   +1 more source